Treatment of behavioral and psychological symptoms of dementia with antidepressions;Psykofarmakologisk behandling af psykiatriske symptomer og adfærdsforstyrrelser ved demens

Ugeskrift for Laeger

Volumn 168, Issue 40, 2006, Pages 3429-3432

  Lolk, Annette ^a,b   Gulmann, Nils Christian ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; OLANZAPINE; RISPERIDONE;

AGGRESSION; ANXIETY DISORDER; BEHAVIOR; CLINICAL FEATURE; DEMENTIA; DRUG EFFICACY; HUMAN; PRESCRIPTION; PSYCHOLOGICAL ASPECT; PSYCHOSIS; SHORT SURVEY; STROKE;

ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DEMENTIA; HUMANS; MENTAL DISORDERS; RISPERIDONE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 33749567008     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Finkel SI, red. Behavioral and psychological signs and symptoms of dementia: implications for research and treatment. Int Psychogeriatrics 1996;8(suppl 3):215-552.
2. Livingston G, Johnston K, Katona C et al. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 2005;162:1996-2021.
3. Bains J, Birks JS, Dening TD. Antidepressants for treating depression in dementia (review). The Cochrane Library, Issue 2, 2006. Chichester, UK: John Wiley & Sons.
4. Lyketsos CG, DelCampo L, Steinberg M et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psych 2003;60:737-46.
5. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in the treatment of emotional disorders in dementia disorders. Br J Psychiatry 1990;157:894-901.
6. Sink K, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia. JAMA 2005;293:596-608.
7. Sundhedsstyrelsen. Sundhedsstyrelsen indskærper landets læger at udvise stor forsigtighed ved behandling med antipsykotika til ældre patienter med demens. Ugeskr Læger 2004;166:1395.
8. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. The Cochrane Library, Issue 1, 2006. Chichester, UK: John Wiley & Sons.
9. Carrier L. Anxiolytics. I: Qizibash N, Schneider LS, Chui H et al, red. Evidence-based dementia practice. Oxford: Blackwell, 2002:678-82.
10. Schneider LS, Tariot PN, Lyketsos CG et al. National Institute of Mental Health clinical antipsychotic trials of intervention effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry 2001;9:346-60.